PLOZALIZUMAB
UNII 4XG66BMN0D

Substance Identification & Data

This profile provides standardized clinical and technical data for Plozalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4XG66BMN0D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610761-46-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4XG66BMN0D

CAS Registry Number

1610761-46-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PLOZALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C88308

National Cancer Institute reference terminology for clinical and research data.

INN ID

10124

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-117

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Plozalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PLOZALIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CC CHEMOKINE RECEPTOR CCR2) (HUMAN-MUS MUSCULUS MONOCLONAL 1D9 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1D9 .KAPPA.-CHAIN, DIMER

PLOZALIZUMAB [INN]

PLOZALIZUMAB [USAN]

PLOZALIZUMAB [WHO-DD]